Ian Read
Founder at POPULATION HEALTH INVESTMENT CO., INC.
Profile
Ian C. Read (born 1953) is a British-born American businessman, CEO of Pfizer.
Early life
Read received a BSc in Chemical Engineering from Imperial College London in 1974. He qualified as a Chartered Accountant in 1978. He is a member of the Pfizer Leadership Team. Read is now an American citizen.
Personal life
Read has a holiday home near Bonita Springs, Florida.
Source @ Wikipedia
Latest news about Ian Read
Ian Read active positions
Companies | Position | Start |
---|---|---|
POPULATION HEALTH INVESTMENT CO., INC. | Founder | 2020-09-10 |
US-China Business Council
US-China Business Council Miscellaneous Commercial ServicesCommercial Services The US-China Business Council is an organization that provides information, advisory, advocacy, and program services to its members. The non-profit company is based in Washington. The American company focuses on shaping the relationship between the United States and China. USCBC offers research and analyses on Chinese government personnel, member newsletters, and advisory services to answer sector-specific and general investment questions. | Director/Board Member | - |
The Carlyle Group, Inc. (California) | Corporate Officer/Principal | - |
Saama Technologies, Inc.
Saama Technologies, Inc. Data Processing ServicesTechnology Services Saama Technologies, Inc. engages in the provision of consulting and systems integration services. It offers study conduct, study planning, and real world and commercial insight solutions The company was founded by Suresh Katta in 1997 and is headquartered in Campbell, CA. | Director/Board Member | 2021-11-18 |
TriNetX, LLC
TriNetX, LLC Medical/Nursing ServicesHealth Services TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA. | Chairman | 2021-02-21 |
avateramedical NV
avateramedical NV Medical SpecialtiesHealth Technology avateramedical NV functions as an investment holding company. The firm operates its business through its subsidiary company: avateramedical GmbH. The company was founded by Hubertus von Grünberg and Jens-Uwe Stolzenburg and is headquartered in Amsterdam, Netherlands. | Director/Board Member | 2020-09-23 |
The Kennedy Center Corporate Fund
The Kennedy Center Corporate Fund Investment Trusts/Mutual FundsMiscellaneous Kennedy Center Corporate Fund operates as a nationwide partnership of distinguished business leaders who help to mobilize corporate partners and secure critical funding. The company was founded by Harold Burson in 1977 and is headquartered in Washington, DC. | Director/Board Member | - |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is an organization that represents the innovative pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer is important in bridging research and development gaps, increasing the availability of vaccines and medicines, and stimulating investment in key industrial areas. The CEO of the company is Thomas Cueni. | Director/Board Member | - |
Catalyst, Inc.
Catalyst, Inc. Miscellaneous Commercial ServicesCommercial Services Catalyst, Inc. provides research and advisory services. The company was founded in 1962 and is headquartered in New York City, NY. | Director/Board Member | - |
░░░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Former positions of Ian Read
Companies | Position | End |
---|---|---|
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Ian Read
Imperial College London | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
KIMBERLY-CLARK CORPORATION | Consumer Non-Durables |
PFIZER, INC. | Health Technology |
ZOETIS INC. | Health Technology |
DXC TECHNOLOGY COMPANY | Technology Services |
VIATRIS INC. | Health Technology |
Private companies | 23 |
---|---|
Curia Global, Inc.
Curia Global, Inc. Miscellaneous Commercial ServicesCommercial Services Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Commercial Services |
Koninklijke DSM NV
Koninklijke DSM NV Chemicals: SpecialtyProcess Industries Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, Innovation Center, and Corporate Activities. The Nutrition segment serves the global industries for animal feed, food and beverage, pharmaceuticals, infant nutrition, dietary supplements, and personal care. The Materials segment deals with specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. The Innovation Center segment focuses on innovation and the growth of DSM's existing core business through adjacent technologies. The Corporate Activities segment consists of operating and service activities as well as other several costs. The company was founded in 1902 and is headquartered in Herleen, the Netherlands. | Process Industries |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is an organization that represents the innovative pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer is important in bridging research and development gaps, increasing the availability of vaccines and medicines, and stimulating investment in key industrial areas. The CEO of the company is Thomas Cueni. | Health Technology |
PF Consumer Healthcare Canada ULC
PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology PF Consumer Healthcare Canada ULC produces anti-infective, anti-inflammatory, cardiovascular and other prescription medicines and consumer healthcare products. It discovers, develops, manufactures and markets prescription medicines for humans and animals as well as over-the-counter healthcare products. The company was founded in 1953 and is headquartered in Kirkland, Canada. | Health Technology |
Catalyst, Inc.
Catalyst, Inc. Miscellaneous Commercial ServicesCommercial Services Catalyst, Inc. provides research and advisory services. The company was founded in 1962 and is headquartered in New York City, NY. | Commercial Services |
Saama Technologies, Inc.
Saama Technologies, Inc. Data Processing ServicesTechnology Services Saama Technologies, Inc. engages in the provision of consulting and systems integration services. It offers study conduct, study planning, and real world and commercial insight solutions The company was founded by Suresh Katta in 1997 and is headquartered in Campbell, CA. | Technology Services |
The Partnership for New York City, Inc.
The Partnership for New York City, Inc. Miscellaneous Commercial ServicesCommercial Services The Partnership for New York City operates as a charitable organization. It is a network of business leaders and corporations working for the economic and cultural betterment of all five boroughs of the city. The firm provides networking opportunities, conducts research, participates in policy making and lobbies government. The company was founded by David Rockefeller in 2002 and is headquartered in New York, NY. | Commercial Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Healthcare Leadership Council
Healthcare Leadership Council Medical/Nursing ServicesHealth Services Healthcare Leadership Council operates as a organization focusing on the provision of a healthcare system. The company is headquartered in Washington, DC. | Health Services |
United States Council for International Business | |
The Council on Competitiveness
The Council on Competitiveness Miscellaneous Commercial ServicesCommercial Services The Council on Competitiveness is a nonpartisan organization that has been advocating for a competitiveness agenda for over three decades. The non-profit company is based in Washington. The organization aims to attract investment and talent, spur the commercialization of new ideas, and enhance productivity to raise the standard of living for all Americans. The council's members include CEOs, university presidents, labor leaders, and national lab directors who provide real-world perspective to policymakers. The council believes that with the right policies, the strengths and potential of the economy far outweigh the current challenges the nation faces on the path to higher growth and greater opportunity for all Americans. Deborah L. Wince-Smith has been the CEO of the American company since 1993. | Commercial Services |
US-China Business Council
US-China Business Council Miscellaneous Commercial ServicesCommercial Services The US-China Business Council is an organization that provides information, advisory, advocacy, and program services to its members. The non-profit company is based in Washington. The American company focuses on shaping the relationship between the United States and China. USCBC offers research and analyses on Chinese government personnel, member newsletters, and advisory services to answer sector-specific and general investment questions. | Commercial Services |
President's Export Council | Government |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
The Kennedy Center Corporate Fund
The Kennedy Center Corporate Fund Investment Trusts/Mutual FundsMiscellaneous Kennedy Center Corporate Fund operates as a nationwide partnership of distinguished business leaders who help to mobilize corporate partners and secure critical funding. The company was founded by Harold Burson in 1977 and is headquartered in Washington, DC. | Miscellaneous |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products. | Health Technology |
Pfizer SA de CV
Pfizer SA de CV Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer SA de CV develops and markets drugs. | Health Technology |
Pfizer Brasil Ltda. | |
TriNetX, LLC
TriNetX, LLC Medical/Nursing ServicesHealth Services TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA. | Health Services |
The Carlyle Group, Inc. (California) | |
avateramedical NV
avateramedical NV Medical SpecialtiesHealth Technology avateramedical NV functions as an investment holding company. The firm operates its business through its subsidiary company: avateramedical GmbH. The company was founded by Hubertus von Grünberg and Jens-Uwe Stolzenburg and is headquartered in Amsterdam, Netherlands. | Health Technology |
Population Health Investment Co., Inc.
Population Health Investment Co., Inc. Financial ConglomeratesFinance Population Health Investment Co., Inc. operates as a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. It intends to focus on companies in the healthcare industry such as the therapeutics sector. The company was founded by Clive A. Meanwell and Ian C. Read on September 11, 2020 and is headquartered in New York, NY. | Finance |
Areteia Therapeutics, Inc.
Areteia Therapeutics, Inc. BiotechnologyHealth Technology Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials. | Health Technology |